Efficacy and Safety of Ultrasonic Ablation to Treat Secondary Hyperparathyroidism in Chronic Kidney Disease Patients
Status:
Completed
Trial end date:
2014-11-01
Target enrollment:
Participant gender:
Summary
It is difficulty for the treatment of secondary hyperparathyroidism in the chronic kidney
disease (CKD) patients who had not succeeded medical therapy and could not get
parathyroidectomy. The investigators suppose that ultrasonic ablation may be a valuable
alternative treatment that help control secondary hyperparathyroidism in CKD patients
presenting with enlarged parathyroid gland(s) visible at ultrasonography.